SEQSTER and Clairyon announce partnership for earlier sepsis intervention

SEQSTER and Clairyon have partnered to improve sepsis detection by integrating real-time patient data with advanced machine learning, aiming to save thousands of lives through earlier intervention and personalized post-discharge monitoring.

SEQSTER PDM, Inc. and Clairyon have entered into a strategic partnership aimed at enhancing sepsis detection by bringing real-time patient data to the table.

Building on Clairyon's 17% relative reduction in sepsis mortality at UC San Diego Health, the partnership pairs its predictive model, COMPOSER, with SEQSTER's 1-Click Patient and 1-Click Records pathways to redefine "Time Zero" (T0) for sepsis detection and accelerate early antibiotic administration. Together, the organizations aim to scale this impact nationally with the potential to save an additional 50,000 lives.

By feeding SEQSTER's unified view of EHRs, diagnostic labs, genomics, and wearables into Clairyon's machine-learning early warning system, the partnership aims to deliver earlier, more accurate sepsis alerts during the critical intervention window when timely treatment can save lives.

SEQSTER's longitudinal data will also power Clairyon's post-discharge surveillance for sepsis survivors, combining wearable integrations with personalized education to create an end-to-end ecosystem that detects early physiological deterioration and triggers timely intervention, from the emergency department to the patient's home.

Visit SEQSTER for more information

 

About the Author

Sign up for our eNewsletters
Get the latest news and updates